Depression in the medically ill

J. Rosenblat, P. Kurdyak, F. Cosci, M. Berk, M. Maes, A. Brunoni, Madeline Li, G. Rodin, R. McIntyre, A. Carvalho
{"title":"Depression in the medically ill","authors":"J. Rosenblat, P. Kurdyak, F. Cosci, M. Berk, M. Maes, A. Brunoni, Madeline Li, G. Rodin, R. McIntyre, A. Carvalho","doi":"10.1177/0004867419888576","DOIUrl":null,"url":null,"abstract":"Background: Depressive disorders are significantly more common in the medically ill compared to the general population. Depression is associated with worsening of physical symptoms, greater healthcare utilization and poorer treatment adherence. The present paper provides a critical review on the assessment and management of depression in the medically ill. Methods: Relevant articles pertaining to depression in the medically ill were identified, reviewed and synthesized qualitatively. A systematic review was not performed due to the large breadth of this topic, making a meaningful summary of all published and unpublished studies not feasible. Notable studies were reviewed and synthesized by a diverse set of experts to provide a balanced summary. Results: Depression is frequently under-recognized in medical settings. Differential diagnoses include delirium, personality disorders and depressive disorders secondary to substances, medications or another medical condition. Depressive symptoms in the context of an adjustment disorder should be initially managed by supportive psychological approaches. Once a mild to moderate major depressive episode is identified, a stepped care approach should be implemented, starting with general psychoeducation, psychosocial interventions and ongoing monitoring. For moderate to severe symptoms, or mild symptoms that are not responding to low-intensity interventions, the use of antidepressants or higher intensity psychotherapeutic interventions should be considered. Psychotherapeutic interventions have demonstrated benefits with small to moderate effect sizes. Antidepressant medications have also demonstrated benefits with moderate effect sizes; however, special caution is needed in evaluating side effects, drug–drug interactions as well as dose adjustments due to impairment in hepatic metabolism and/or renal clearance. Novel interventions for the treatment of depression and other illness-related psychological symptoms (e.g. death anxiety, loss of dignity) are under investigation. Limitations: Non-systematic review of the literature. Conclusion: Replicated evidence has demonstrated a bidirectional interaction between depression and medical illness. Screening and stepped care using pharmacological and non-pharmacological interventions is merited.","PeriodicalId":8576,"journal":{"name":"Australian & New Zealand Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian & New Zealand Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0004867419888576","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Background: Depressive disorders are significantly more common in the medically ill compared to the general population. Depression is associated with worsening of physical symptoms, greater healthcare utilization and poorer treatment adherence. The present paper provides a critical review on the assessment and management of depression in the medically ill. Methods: Relevant articles pertaining to depression in the medically ill were identified, reviewed and synthesized qualitatively. A systematic review was not performed due to the large breadth of this topic, making a meaningful summary of all published and unpublished studies not feasible. Notable studies were reviewed and synthesized by a diverse set of experts to provide a balanced summary. Results: Depression is frequently under-recognized in medical settings. Differential diagnoses include delirium, personality disorders and depressive disorders secondary to substances, medications or another medical condition. Depressive symptoms in the context of an adjustment disorder should be initially managed by supportive psychological approaches. Once a mild to moderate major depressive episode is identified, a stepped care approach should be implemented, starting with general psychoeducation, psychosocial interventions and ongoing monitoring. For moderate to severe symptoms, or mild symptoms that are not responding to low-intensity interventions, the use of antidepressants or higher intensity psychotherapeutic interventions should be considered. Psychotherapeutic interventions have demonstrated benefits with small to moderate effect sizes. Antidepressant medications have also demonstrated benefits with moderate effect sizes; however, special caution is needed in evaluating side effects, drug–drug interactions as well as dose adjustments due to impairment in hepatic metabolism and/or renal clearance. Novel interventions for the treatment of depression and other illness-related psychological symptoms (e.g. death anxiety, loss of dignity) are under investigation. Limitations: Non-systematic review of the literature. Conclusion: Replicated evidence has demonstrated a bidirectional interaction between depression and medical illness. Screening and stepped care using pharmacological and non-pharmacological interventions is merited.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抑郁症在医学上是病态的
背景:与普通人群相比,抑郁症在疾病患者中更为常见。抑郁症与身体症状的恶化、更多的医疗保健利用和较差的治疗依从性有关。本文对医学疾病中抑郁症的评估和管理进行了综述。方法:对医学疾病中抑郁症的相关文献进行定性分析、综述和综合。由于本课题的广泛性,没有进行系统综述,因此无法对所有已发表和未发表的研究进行有意义的总结。值得注意的研究由不同的专家进行审查和综合,以提供一个平衡的总结。结果:抑郁症在医疗环境中经常被低估。鉴别诊断包括谵妄,人格障碍和抑郁症继发于物质,药物或其他医疗条件。在适应障碍的背景下,抑郁症状最初应通过支持性心理方法进行管理。一旦发现轻度至中度重度抑郁发作,应实施阶梯式护理方法,从一般心理教育、社会心理干预和持续监测开始。对于中度至重度症状,或对低强度干预无效的轻度症状,应考虑使用抗抑郁药或更高强度的心理治疗干预。心理治疗干预已证明具有小到中等效应的益处。抗抑郁药物也被证明具有中等效应;然而,在评估副作用、药物-药物相互作用以及由于肝代谢和/或肾清除损害而调整剂量时需要特别小心。正在研究治疗抑郁症和其他与疾病有关的心理症状(如死亡焦虑、丧失尊严)的新干预措施。局限性:文献的非系统回顾。结论:重复证据表明抑郁与医学疾病之间存在双向相互作用。使用药理学和非药理学干预措施进行筛查和阶梯式护理是值得的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mortality in people living with dementia who self-harmed: An Australian data linkage study Exploring the use of electroconvulsive therapy in the anticoagulated population: A systematic review Evaluation of Monitoring Practices in Patients on Novel Antipsychotics Myoclonus in Psychiatry Pain Medicine: New Frontiers in Moving from Cell to Soul, and Back
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1